Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine
Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against SARS-CoV-2. Numerous vaccines have been designed and tested in limited clinical trials in various countries. Among them, the Sputnik V vaccine has shown a relatively safe profile and, t...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2022-01-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/3042 |